Company:  ENDOLOGIX INC /DE/ (ELGX)
Form Type:  424B5
Filing Date:  8/13/2019 
CIK:  0001013606 
Address:  2 MUSICK 
City, State, Zip:  IRVINE, California 92618 
Telephone:  (949) 598-4741 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$4.18  
Change: 
-0.18 (-4.13%)  
Trade Time: 
01:50 PM EST  
Market Cap: 
$73.62M
Trade ELGX now with

© 2019  
Description of Business
We develop, manufacture, market and sell innovative medical devices for the treatment of aortic disorders. Our products are intended for the minimally invasive endovascular treatment of abdominal aortic aneurysms ("AAA"). Our AAA products are built on one of two platforms: * Traditional minimally-invasive endovascular aneurysm repair ("EVAR"); or * Endovascular aneurysm sealing ("EVAS"), our innovative solution for sealing the aneurysm sac while maintaining blood flow. Our current EVAR products include the AFX® Endovascular AAA System (the "AFX System"), the VELA® Proximal Endograft ("VELA") and the Ovation® Abdominal Stent Graft System (the "Ovation System"). Our current EVAS product is the Nellix® Endovascular Aneurysm Sealing System (the "Nellix EVAS System").
Register and access this filing in:     
  FORM 424B5
    ABOUT THIS PROSPECTUS SUPPLEMENT
    CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
    The Offering
    RISK FACTORS
    USE OF PROCEEDS
    DILUTION
    MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S ...
    PLAN OF DISTRIBUTION
    LEGAL MATTERS
    EXPERTS
    WHERE YOU CAN FIND MORE INFORMATION
    TABLE OF CONTENTS
    RISK FACTORS
    USE OF PROCEEDS
    DESCRIPTION OF CAPITAL STOCK
    Transfer Agent and Registrar
    DESCRIPTION OF WARRANTS
    DESCRIPTION OF UNITS
      INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE